Search Results - "Forgeson, Garry"
-
1
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Published in Journal of clinical oncology (01-07-2010)“…To determine whether adding bevacizumab, with or without mitomycin, to capecitabine monotherapy improves progression-free survival (PFS) in patients with…”
Get full text
Journal Article -
2
Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service
Published in Internal medicine journal (01-03-2020)“…Background Neoadjuvant chemotherapy (NACT) is increasingly used for managing locally advanced and high risk non‐metastatic breast cancer. Aims To describe…”
Get full text
Journal Article -
3
A prospective audit on use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline/cyclophosphamide
Published in New Zealand medical journal (16-04-2021)“…Assesses current use of prophylactic antiemetics and rates of chemotherapy-induced nausea and vomiting (CINV) in patients under the care of MidCentral Regional…”
Get full text
Journal Article -
4
High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres
Published in BJU international (01-06-2022)“…Objective To report treatment patterns and survival outcomes of patients with relapsed and refractory metastatic germ cell tumours (GCTs) treated with…”
Get full text
Journal Article -
5
Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR
Published in Journal of clinical oncology (20-02-2021)“…Abstract only 382 Background: High dose chemotherapy (HDCT) with autologous stem-cell transplant (ASCT) is effective in advanced germ cell tumours (GCT) that…”
Get full text
Journal Article -
6
Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy
Published in New Zealand medical journal (01-11-2013)“…Contributes the first reported case of gemcitabine/oxaliplatin (GemOx) chemotherapy used for recurrent non-seminomatous germ cell tumour of the testis…”
Get full text
Journal Article -
7
Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial
Published in Clinical genitourinary cancer (01-02-2015)“…Micro-Abstract This study prospectively evaluated the benefits of the addition of bone-specific therapy to targeted therapy in patients with renal cell…”
Get full text
Journal Article -
8
A workforce survey of New Zealand medical oncologists
Published in New Zealand medical journal (15-03-2013)“…Presents the findings of a Medical Oncology Work Group (MOWG) survey of vocationally registered medical oncologists regarding workload and other issues…”
Get full text
Journal Article -
9
The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre
Published in New Zealand medical journal (24-01-2003)“…Studies the prevalence and patterns of complementary/alternative medicine (CAM) use in cancer patients managed by a NZ regional cancer treatment centre…”
Get full text
Journal Article -
10
RAD001 and zoledronic acid in patients with renal cell carcinoma with bone metastases (RAZOR): A randomized phase II trial
Published in Journal of clinical oncology (20-02-2013)“…Abstract only 402 Background: Bone metastases (BM) from renal cell carcinoma (RCC) are common, cause morbidity, and have been identified as an adverse…”
Get full text
Journal Article -
11
Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy
Published in New Zealand medical journal (01-11-2013)“…The first reported case of gemcitabine/oxaliplatin (GemOx) chemotherapy used for recurrent non-seminomatous germ cell tumour of the testis metastatic to the…”
Get full text
Journal Article -
12
RAD001 and zoledronic acid in renal cell carcinoma patients with bone metastases (RAZOR): A randomized phase II trial
Published in Journal of clinical oncology (20-05-2012)“…Abstract only e15054 Background: Bone metastases (BM) from renal cell carcinoma (RCC) are common, cause major morbidity and have been identified as an adverse…”
Get full text
Journal Article -
13
Seek and ye shall find : Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration
Published in New Zealand medical journal (13-04-2007)“…Presents the case of a patient who developed a rapidly progressive cerebellar ataxia and underwent extensive investigations before a paraneoplastic aetiology…”
Get full text
Journal Article -
14
Seek and ye shall find: Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration
Published in New Zealand medical journal (13-04-2007)“…Paraneoplastic neurological syndromes (PNS) are rare complications of cancer and may be the presenting sign of an occult malignancy. Diagnosis of PNS is often…”
Get full text
Journal Article -
15
The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre
Published in New Zealand medical journal (24-01-2003)“…To study the prevalence and patterns of complementary/alternative medicine (CAM) use in cancer patients managed by a New Zealand regional cancer treatment…”
Get full text
Journal Article -
16
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide
Published in Cancer chemotherapy and pharmacology (01-01-1989)“…A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without…”
Get full text
Journal Article